Xenon Pharmaceuticals Statistics Share Statistics Xenon Pharmaceuticals has 77.11M
shares outstanding. The number of shares has increased by 1.14%
in one year.
Shares Outstanding 77.11M Shares Change (YoY) 1.14% Shares Change (QoQ) 0.49% Owned by Institutions (%) 94.47% Shares Floating 71.6M Failed to Deliver (FTD) Shares 202 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 7.04M, so 9.13% of the outstanding
shares have been sold short.
Short Interest 7.04M Short % of Shares Out 9.13% Short % of Float 10.18% Short Ratio (days to cover) 11.18
Valuation Ratios The PE ratio is -13.03 and the forward
PE ratio is -8.5.
Xenon Pharmaceuticals's PEG ratio is
-1.27.
PE Ratio -13.03 Forward PE -8.5 PS Ratio 0 Forward PS 154.5 PB Ratio 4.04 P/FCF Ratio -16.55 PEG Ratio -1.27
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Xenon Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 17.85,
with a Debt / Equity ratio of 0.01.
Current Ratio 17.85 Quick Ratio 17.85 Debt / Equity 0.01 Debt / EBITDA -0.04 Debt / FCF -0.05 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-741.55K Employee Count 316 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -4.09M Effective Tax Rate 1.72%
Stock Price Statistics The stock price has increased by -1.26% in the
last 52 weeks. The beta is 1.17, so Xenon Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.17 52-Week Price Change -1.26% 50-Day Moving Average 36.38 200-Day Moving Average 35.53 Relative Strength Index (RSI) 59.7 Average Volume (20 Days) 839,685
Income Statement
Revenue n/a Gross Profit -2.56M Operating Income -279.3M Net Income -234.33M EBITDA -235.86M EBIT -238.42M Earnings Per Share (EPS) -3.01
Full Income Statement Balance Sheet The company has 142.71M in cash and 9.02M in
debt, giving a net cash position of 133.7M.
Cash & Cash Equivalents 142.71M Total Debt 9.02M Net Cash 133.7M Retained Earnings -899.47M Total Assets 674.28M Working Capital 467.2M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -181.39M
and capital expenditures -3.08M, giving a free cash flow of -184.46M.
Operating Cash Flow -181.39M Capital Expenditures -3.08M Free Cash Flow -184.46M FCF Per Share -2.37
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
